Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News PaxMedica Inc (EM) PXMD

Healthcare Biotechnology
PaxMedica, Inc., a clinical stage biopharmaceutical company, focuses on the development of anti-purinergic drug therapies for the treatment of disorders with intractable neurologic symptoms. Its lead product candidate is PAX-101 that is in Phase 3 clinical trials, an intravenous formulation of suramin for the treatment of autism spectrum disorder, myalgic encephalomyelitis/chronic fatigue... see more

Current News (EXPM:PXMD)

PaxMedica Announces First Patent Allowance for Suramin Intranasal Formulation in the treatment of Autism Spectrum Disorder and Other Conditions

ACCESS Newswire January 14, 2025

PaxMedica Secures Immediate Exercise of Warrants

ACCESS Newswire September 3, 2024

PaxMedica Reports First Patient Treated with PAX-101 for Fatal African Sleeping Sickness Infection

ACCESS Newswire August 27, 2024

PaxMedica Files Nasdaq Delisting Appeal Notice and Prepares for Upcoming FDA Meeting on PAX-101

GlobeNewswire May 15, 2024

PaxMedica Provides Company Update and Continues to Advance PAX-101 Regulatory Strategy

GlobeNewswire May 7, 2024

PaxMedica Responds to Emergency Request for IV Suramin and Commits to Provide Immediate Access to PAX-101

GlobeNewswire April 23, 2024

PaxMedica Receives Emergency Request for IV Suramin from African Health Ministry for Use in Treating Fatal Sleeping Sickness

GlobeNewswire April 16, 2024

PaxMedica Achieves Key Milestone in the Development of PAX-101 And Provides Update on Potential NDA Submission

GlobeNewswire April 11, 2024

PaxMedica Updated Company Presentation Highlighting Innovations in Autism Spectrum Disorder Treatments

GlobeNewswire March 13, 2024
View More News ››

Opinion & Analysis (EXPM:PXMD)

No current opinion is available.
View More Opinion ››

Bullboard Posts (EXPM:PXMD)

Paxmedica, Inc. (PXMD): A Promising Biopharmaceutical Compan

http://beyondspx.com/2024/08/03/paxmedica-inc-pxmd-a-promising-biopharmaceutical-company-navigating-challenges/
MikeTester - August 3, 2024

PP

Imagine if you pay 1.30 for the placement then one week later it's  75 cents. All because an algorithm or shorters. BS.
Steve33 - December 5, 2023

PXMD .....Anyone for a game of Spearcatching?

Post RS & Post P.O....cheaper than a large slurpee ; )
Iseneschal - November 29, 2023

RE:PXMD....NR this a.m....Fluff promo ; )

NR this a.m on P.O pricing.....Told ya ; ) Cheers !
Iseneschal - November 20, 2023

PXMD....NR this a.m....Fluff promo ; )

Just waiting for the P.O to be announced JMHO
Iseneschal - November 17, 2023

PXMD .... Only Bagholders and FOMO's left in this ; )

Waiting for the P.O announcement Cheers 
Iseneschal - November 15, 2023
View more Bullboard ››

Birchtech Corp.

Birchtech Corp.

Birchtech Corp., an environmental services and technology company, engages in developing and delivering solutions to the ...
View More »

Podcasts